silybin has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, C; Agarwal, R; Sharma, Y; Tyagi, A | 1 |
| Choe, JH; Han, J; Kim, JH; Kim, JS; Kim, S; Lee, JE; Nam, SJ; Yang, JH | 1 |
2 other study(ies) available for silybin and transforming growth factor alpha
| Article | Year |
|---|---|
Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
Topics: Androgens; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Autocrine Communication; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; RNA, Messenger; Silybin; Silymarin; Time Factors; Transforming Growth Factor alpha | 2008 |
Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.
Topics: Antioxidants; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Hyaluronan Receptors; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Real-Time Polymerase Chain Reaction; RNA, Messenger; Silybin; Silymarin; Transforming Growth Factor alpha | 2011 |